Home Back Issues May 2010 Genentech invests $400 million in Oregon

Genentech invests $400 million in Oregon

| Print |  Email
Articles - May 2010
Friday, April 16, 2010
starkmangovernor
Genentech’s Barry Starkman presents a T-shirt to Gov. Ted Kulongoski. Starkman oversees 250
employees at the company’s new Hillsboro facility.
OREGON BUSINESS PHOTO

Since purchasing 75 acres of land in Hillsboro in 2006, the San Francisco-based pharmaceutical giant Genentech has invested $400 million in Oregon and created 250 jobs at its new fill/finish and distribution facility. Plant manager Barry Starkman spoke with Oregon Business after a ribbon-cutting ceremony in early April.

Where are you from?
Originally, I’m from New Jersey. Spent most of my life there. Went to college in Pennsylvania, worked for a while there, then spent 24 years with Merck, working overseas in Belgium. I joined Genentech about five years ago.

You were involved with Genentech’s move to Oregon from the beginning?
I started working on this in the summer of 2005, about six months after I joined Genentech. For a while I was based out of San Francisco. We moved to Oregon in July of 2007.

Describe your experience expanding into Oregon.
It’s been an amazing experience. Oregon set itself apart from the other places we looked at. People were genuine about wanting us to be here. It wasn’t just a façade. It was real. They were looking to diversify the portfolio of businesses here and they were ready to take it all the way.

Did that change after you bought the property?
Not at all. Once we made the decision to come here, it didn’t stop. It was about everything they could do to bring this to reality. A friend of mine with another pharmaceutical company has been trying to do a similar project, and the last time I talked to him he still hadn’t gotten the money from the state. The promises still weren’t fulfilled. Here, every single promise was fulfilled.

Your experience seems to contradict the criticism the state has gotten lately for being anti-business.
I have not experienced that. I don’t know whether it’s something special in Hillsboro as opposed to different places, but I can tell you that my experience in Hillsboro has been extremely positive. Any time we ran into an issue during construction they were right there doing what they could.

What about the tax increases that just passed? How do they affect you?
From my vantage point of running this facility, it’s had no impact at all. There’s nothing that has or will change the course that we’re on. We are on track, and this facility is a key strategic component.

Are you happy with the job Hoffman Construction did?
We didn’t know anything about Hoffman. But they presented themselves extremely well. They had the contacts here, they had good relationships with the building trades council, and they delivered a beautiful building to us. It was different for us to do a design-build project, which we hadn’t done before. That was a little risky on our end, but the rewards have paid off. And we maintain a great relationship with them.

What about the 300 employees you’ll have when fully operational?
About half of our employees are transplants from California. The rest have been hired locally, or through national searches for specialized engineers. We also developed a program (with state funding) at Portland Community College and provided scholarships for the first two cohorts of students to go through it. They went for free, and out of those 40-plus students I think we hired 27.

Are these biotech jobs?
We’re proud to say we are part of the biotech process. It’s a vertically integrated process from end to end, and we’re the final step before the medicine goes to the patient.

Genentech is a perennial pick for Fortune’s 100 Best Companies to Work For. What puts the company on that list year after year?
There are a lot of things about Genentech that contribute to the culture. It’s the T-shirt and jeans culture we have, the great benefits we offer and the great salaries we pay people. It’s the bonuses and stock options all levels of employees get, whether you are sweeping the floor as a maintenance worker or the CEO... But the most important thing, and what attracted me here, is the energy around patients. A woman I know is a breast cancer patient, and she’s using Avastin [a tumor-starving cancer medication developed by Genentech] as part of the clinical trial. She was here the day we packaged Avastin for the first time. She spoke to our entire employee population about her experiences. That gives you a sense of purpose. It’s easy to get up to come to work here in the morning.

BEN JACKLET
 

More Articles

The 2014 List: The Top 33 Large Companies to Work, For in Oregon

March 2014
Thursday, February 27, 2014

100best14logoWebOur 100 Best Companies project turned 21 this year, so pop open the Champagne. Our latest survey gives us plenty to cheer.

 


Read more...

Small business sales go big

March 2014
Tuesday, February 25, 2014

BY BRANDON SAWYER

Sales of small businesses surged in 2013 according to the biggest Internet marketplace of such transactions, BizBuySell, increasing to 7,056 reported sales, a 24% increase over 2012, when they dropped 7%. Portland Metro sales tracked by the site grew 9% to 73, capping three years of solid growth. On top of that, Portland’s median sale price jumped 67% to $250K, versus just 13% to $180K nationally. Portland was one of just six metros tracked where the median sale price matched the median asking price, with sellers getting, on average, 92% of what they asked.

BTNMarch14 tableBTNMarch14 line


BTNMarch14 piePDXBTNMarch14 pieUSA


Read more...

The future of money

March 2014
Tuesday, February 25, 2014
BY JAKE THOMAS

An ancient institution moves slowly into the digital age. 


Read more...

Spring thaw

News
Thursday, April 17, 2014
Spring ThawBY JASON NORRIS | OB BLOGGER

The “polar vortex” of 2014 seems to have finally thawed and we believe this change in weather will bring more sunshine to the U.S. economy as well.


Read more...

Eking out a living

News
Tuesday, April 08, 2014
04.08.14 thumb ourtable-coopfarmsBY HANNAH WALLACE | OB BLOGGER

It may be obvious, but most farmers don’t make a lot of money. According to preliminary data from the 2012 Agriculture Census, 52% of America’s 2.1 million principal farm-operators don’t call farming their primary occupation. Farm cooperatives may offer a solution.


Read more...

Video: Kickstarting Oregon business

News
Thursday, March 27, 2014
02.04.14 Thumbnail VideoBY JESSICA RIDGWAY | OB WEB EDITOR

Watch this OB Original Video about three Oregon companies and how crowd-funding "kickstarted" their business ideas.


Read more...

Branching out

March 2014
Tuesday, February 25, 2014
DSC04185BY LINDA BAKER

A blueberry bush is a blueberry bush — except when it’s a blueberry tree.


Read more...
Oregon Business magazinetitle-sponsored-links-02
SPONSORED LINKS